Together, with our partners at the PHARMO Institute, we provide real world evidence (RWE) expertise and access to quick turnaround research that leverages our unique data sets in a wide variety of indications, including diabetes, respiratory, renal disease, dementia, and cardiovascular disease.
The PHARMO Institute, part of Lumanity, is a global leader in pharmacoepidemiology and pharmacovigilance based in the Netherlands. Dutch data is representative of Western Europe and can be used in global studies as a robust proxy or complement to EU-5. The PHARMO Institute capabilities and experience enable us to deliver on a wide range of RWE use cases.
Download our fact sheets for additional details and information on our disease and treatment characterization, healthcare resource utilization, treatment patterns, burden of disease, clinical grouping, and comparative effectiveness, safety, and tolerability in these select indications.
Contact us
Lumanity can be counted on for service and quality. We utilize proven processes supported by technologically advanced resources to produce high-quality services, with guaranteed satisfaction.
If you would like more information or would like to speak with us about your research insight needs, specific study objectives, and delivery please contact us.
